Also trades as: ZYDUSWELL.BO (BSE) · $vol 0M
ZYDUSWELL.NS NSE
Zydus Wellness Limited
1W: -5.2%
1M: -6.7%
3M: -17.4%
YTD: +18.4%
1Y: +26.6%
3Y: +73.3%
5Y: +15.8%
₹484.75 ($5.03)
-8.50 (-1.72%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$103.1B
+60.0% ▲
5Y CAGR: +12.7%
Total Liabilities
$44.8B
+481.8% ▲
5Y CAGR: +32.5%
Shareholders Equity
$58.3B
+2.7% ▲
5Y CAGR: +5.0%
Cash & Investments
$1.2B
-10.9% ▼
5Y CAGR: -14.5%
Total Debt
$32.0B
+1600.9% ▲
5Y CAGR: +42.2%
Net Debt
$30.9B
+2442.5% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $1.2B | $370M | $800M | $667M | $1.1B |
| Short-Term Investments | $270M | $706M | $2.4B | $425M | $42M |
| Cash & ST Investments | $2.0B | $1.1B | $3.2B | $1.3B | $1.2B |
| Net Receivables | $1.6B | $2.3B | $3.2B | $3.7B | $3.9B |
| Inventory | $3.6B | $4.6B | $4.7B | $5.2B | $7.6B |
| Other Current Assets | $897M | $993M | $4M | $890M | $1.0B |
| Total Current Assets | $8.1B | $9.1B | $12.1B | $11.0B | $13.7B |
| Property, Plant & Equip. | $2.6B | $2.9B | $2.6B | $3.1B | $3.4B |
| Goodwill & Intangibles | $44.7B | $44.6B | $44.6B | $48.3B | $82.8B |
| Long-Term Investments | $5M | $24M | $7M | $7M | $71M |
| Other Non-Current Assets | $264M | $254M | $599M | $523M | $2.0B |
| Total Non-Current Assets | $48.8B | $49.3B | $49.3B | $53.4B | $89.4B |
| Total Assets | $56.9B | $58.3B | $61.5B | $64.4B | $103.1B |
| — Liabilities — | |||||
| Accounts Payable | $3.6B | $3.1B | $3.6B | $4.3B | $4.6B |
| Short-Term Debt | $3.2B | $2.9B | $3.2B | $1.9B | $1.6B |
| Deferred Revenue | $63M | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $194M | $307M | $625M | $1.3B | $1.1B |
| Total Current Liabilities | $7.7B | $6.9B | $7.7B | $7.5B | $7.3B |
| Long-Term Debt | $625M | $0 | $0 | $0 | $30.3B |
| Other Non-Current Liab. | $138M | $146M | $176M | $230M | $743M |
| Total Non-Current Liabilities | $813M | $181M | $215M | $248M | $37.5B |
| Total Liabilities | $8.5B | $7.1B | $7.9B | $7.7B | $44.8B |
| — Equity — | |||||
| Common Stock | $636M | $636M | $636M | $636M | $636M |
| Retained Earnings | $12.0B | $14.8B | $17.1B | $20.3B | $21.8B |
| Accumulated OCI | $453M | $4M | $2M | $447M | $405M |
| Total Stockholders Equity | $48.4B | $51.2B | $53.6B | $56.7B | $58.3B |
| Total Liabilities & Equity | $56.9B | $58.3B | $61.5B | $64.4B | $103.1B |
| — Key Metrics — | |||||
| Total Debt | $3.9B | $3.0B | $3.3B | $1.9B | $32.0B |
| Net Debt | $2.7B | $2.6B | $2.5B | $1.2B | $30.9B |
| Total Investments | $275M | $730M | $2.4B | $432M | $113M |